Pfizer concludes acquisition of Hospira

05 Sep 2015 Evaluate

Pfizer has completed its acquisition of Hospira, Inc. on September 03, 2015, creating a leading Global Established Pharmaceutical (GEP) Business. Hospira is the world’s leading provider of injectable drugs and infusion technologies and a global leader in biosimilars.

Pfizer has produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections.


Pfizer Share Price

4438.10 0.00 (0.00%)
18-May-2024 12:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.85
Dr. Reddys Lab 5812.50
Cipla 1403.90
Zydus Lifesciences 1104.45
Lupin 1661.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.